Koyfin Home > Directory > Health Care > Amicus Therapeutics > Altman Z-score

Amicus Therapeutics Altman Z-score Chart (FOLD)

Amicus Therapeutics annual/quarterly Altman Z-score from 2007 to 2018.
  • Amicus Therapeutics Altman Z-score for the quarter ending September 09, 2018 was -0.10 a 2,348.85% decrease of -2.25 year over year
  • Amicus Therapeutics Altman Z-score for the last 12 months ending September 09, 2018 was 1.06 a 26.60% increase of 0.28 year over year
  • Amicus Therapeutics Annual Altman Z-score for 2017 was 0.73 a 170.98% increase of 1.25 from 2016
  • Amicus Therapeutics Annual Altman Z-score for 2016 was -0.52 a -104.84% increase of 0.55 from 2015
  • Amicus Therapeutics Annual Altman Z-score for 2014 was -1.07 a -274.45% increase of 2.93 from 2013
Other Balance Sheet Metrics:
  • Amicus Therapeutics Total Assets for the quarter ending September 09, 2018 was $839m a 25.23% increase of 212m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Equity for the quarter ending September 09, 2018 was $411m a 14.14% increase of 58m year over year
View Chart On Koyfin

Quarterly FOLD Altman Z-score Data

09/2018-0.10
06/20184.59
03/20182.67
12/20172.16
09/20172.51
06/2017-0.73
03/2017-0.77
12/2016-0.60
09/2016-0.55
12/20140.48

Annual FOLD Altman Z-score Data

20170.73
2016-0.52
2014-1.07
2013-3.99
2012-0.95
2011-4.03
2010-2.28
20096.64
20080.87
20072.02